Latest Typical antipsychotic Stories
INDIANAPOLIS, Ind., Oct. 7 /PRNewswire-FirstCall/ -- Eli Lilly and Company today announced that it has resolved a multi-state investigation involving 32 states and the District of Columbia (DC) related to the sales, marketing and promotion of its antipsychotic medication Zyprexa(R) (olanzapine).
BARCELONA, Spain, Sept. 2 /PRNewswire-FirstCall/ -- Final results from a 24-week study presented today at a major medical meeting in Barcelona suggest that investigational olanzapine long-acting injection (LAI) therapeutic doses showed a maintenance of treatment benefit for up to six months.
WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc.
SAN DIEGO, May 22 /PRNewswire/ -- After administration of paliperidone extended-release (ER) tablets, blood levels of the drug were not affected when given with a common antidepressant, according to new data presented today at the 160th Annual Meeting of the American Psychiatric Association.
High levels of sugar in the blood, also known as hyperglycemia, is a common finding in individuals taking atypical antipsychotics who are thought to have normal blood sugar levels.
Atypical antipsychotic drugs seem to confer a small increased risk for death when used in people with dementia, concludes a team of researchers from the Keck School of Medicine of the University of Southern California in a meta-analysis of 15 clinical trials published in the October 19 issue of the Journal of the American Medical Association.
A large study funded by NIH's National Institute of Mental Health (NIMH) provides, for the first time, detailed information comparing the effectiveness and side effects of five medications â€“ both new and older medications â€“ that are currently used to treat people with schizophrenia.
By Anne Harding NEW YORK (Reuters Health) - So-called atypical antipsychotic drugs are just as likely as older antipsychotics drugs to cause movement disorders in older people with dementia, according to a new study.
A multi-site research group working under contract with NIMH finds that Risperidone, one of the newer anti-psychotic medications, is safe and effective for controlling aggressive and violent behavior in autistic children with minimal side effects for up to six months. The medication also decreases repetitive behaviors and increases social interaction with these children.
- An armed gangster.